Clinical trial
Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B: Phase I/ II Study
NCT04357600 is registered in ClinicalTrials.gov with PT. Prodia Stem Cell Indonesia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Umbilical Cord Mesenchymal Stem Cell for Liver Cirrhosis Patient Caused by Hepatitis B: Phase I/ II Study
- Lead sponsor
- PT. Prodia Stem Cell Indonesia
- Phase
- Phase 1/2
- Overall status
- Enrolling by invitation
- Start date
- May 17, 2018
- Completion date
- December 20, 2028
- Enrollment
- 12 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
liver cirrhoses